News Update on Availability of Byooviz, a Biosimilar to Lucentis By Brian Park, PharmD Publish Date June 2, 2022
Drugs in the Pipeline Nyxol Ophthalmic Solution Looks Promising for Night Vision Disturbances By Brian Park, PharmD Publish Date May 20, 2022
News Verkazia Now Available for Vernal Keratoconjunctivitis By Brian Park, PharmD Publish Date May 2, 2022
Drugs in the Pipeline Trials Evaluating Novel Eye Drop Candidate for Presbyopia Meet Endpoints By Brian Park, PharmD Publish Date April 21, 2022
Drugs in the Pipeline Trial Investigating New Vuity Dosing Option for Presbyopia Meets Endpoint By Brian Park, PharmD Publish Date April 5, 2022
News Xipere Now Available for Macular Edema Associated With Uveitis By Brian Park, PharmD Publish Date March 28, 2022
Drugs in the Pipeline Pegcetacoplan Continues to Reduce Geographic Atrophy Lesion Growth: 18-Month Data By Lea Eslava-Kim, PharmD Publish Date March 16, 2022
News Lastacaft Eye Drops Now Available Over-the-Counter By Brian Park, PharmD Publish Date March 15, 2022
News FDA Approves Disposable Contacts With Antihistamine for Allergic Conjunctivitis By Brian Park, PharmD Publish Date March 4, 2022
Generics News First Generic Version of Restasis Gets FDA Approval By Brian Park, PharmD Publish Date February 3, 2022
New Drug Products January 2022: 5 Notable Drug Approvals By Diana Ernst, RPh Publish Date February 2, 2022
News Vabysmo Approved for Wet AMD, Diabetic Macular Edema By Brian Park, PharmD Publish Date January 31, 2022
News Kimmtrak Approved for Unresectable or Metastatic Uveal Melanoma By Brian Park, PharmD Publish Date January 26, 2022
Drugs in the Pipeline Intravitreal Gene Therapy Fast Tracked for X-Linked Retinitis Pigmentosa By Brian Park, PharmD Publish Date January 11, 2022
Drugs in the Pipeline Visomitin Gets Orphan Drug Status for Leber Hereditary Optic Neuropathy By Brian Park, PharmD Publish Date December 17, 2021